**Topical Agents: Corticosteroids**

|            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| ---------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Criteria 1 | Non-Preferred- Alclometasone, Apexicon E, Betamethasone Dipropionate, Betamethasone Dipropionate/Calcipotriene Susp, Betamethasone Valerate Aerosol Foam, Bryhali, Clocortolone Pivalate, Cordran Tape, Desonate Gel, Desonide Lotion, Desoximetasone, Fluocinolone Acetonide 0.01% Oil, Fluocinolone Acetonide 0.025%, 0.1%, Fluticasone Propionate Lotion, Halcinonide Cream, Halobetasol Propionate, Hydrocortisone Butyrate, Valerate, Halog, Impeklo, Pandel, Triamcinolone Spray |

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Topical Agents: Corticosteroids</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred Products</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code(s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>ALCLOMETASONE</td>
<td>007636</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ALCLOMETASONE</td>
<td>007637</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>APEXICON E</td>
<td>041729</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BETAMETHASONE DIPROPIONATE</td>
<td>007568</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BETAMETHASONE DIPROPIONATE</td>
<td>007569</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BETAMETHASONE DIPROPIONATE</td>
<td>007570</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BETAMETHASONE DIPROPIONATE</td>
<td>016429</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BETAMETHASONE DIPROPIONATE/CALCIPOTRIENE SUSP</td>
<td>063988</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BETAMETHASONE VALERATE AEROSOL FOAM</td>
<td>026471</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BRYHALI</td>
<td>079262</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>CLOCORTOLONE PIVALATE</td>
<td>007585</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>CORDRAN TAPE</td>
<td>007601</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DESONATE GEL</td>
<td>062148</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DESONIDE LOTION</td>
<td>016650</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DESOXIMETASONE</td>
<td>007581</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DESOXIMETASONE</td>
<td>007582</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DESOXIMETASONE</td>
<td>007583</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DESOXIMETASONE</td>
<td>007584</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DESOXIMETASONE</td>
<td>041987</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DESOXIMETASONE</td>
<td>070883</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FLUOCINOLONE ACETONIDE 0.01% OIL</td>
<td>007507</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FLUOCINOLONE ACETONIDE 0.01% OIL</td>
<td>058950</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FLUOCINOLONE ACETONIDE 0.025%, 0.1%</td>
<td>007609</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FLUOCINOLONE ACETONIDE 0.025%, 0.1%</td>
<td>007611</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FLUOCINOLONE ACETONIDE 0.025%, 0.1%</td>
<td>015562</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FLUTICASONE PROPIONATE LOTION</td>
<td>059177</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HALCINONIDE CREAM</td>
<td>007625</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HALOBETASOL PROPIONATE</td>
<td>015605</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HALOBETASOL PROPIONATE</td>
<td>015606</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HALOBETASOL PROPIONATE</td>
<td>075826</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HALOBETASOL PROPIONATE</td>
<td>079214</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCORTISONE BUTYRATE, VALERATE</td>
<td>007530</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCORTISONE BUTYRATE, VALERATE</td>
<td>007531</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCORTISONE BUTYRATE, VALERATE</td>
<td>016897</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCORTISONE BUTYRATE, VALERATE</td>
<td>018275</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCORTISONE BUTYRATE, VALERATE</td>
<td>053275</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCORTISONE BUTYRATE, VALERATE</td>
<td>007532</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCORTISONE BUTYRATE, VALERATE</td>
<td>007533</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HALOG</td>
<td>007625</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HALOG</td>
<td>007627</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HALOG</td>
<td>007628</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>IMPEKLO</td>
<td>081125</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>PANDEL</td>
<td>030797</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRIAMCINOLONE SPRAY</td>
<td>062564</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong></th>
<th><strong>Question ID</strong></th>
<th><strong>Default Next Question ID</strong></th>
<th><strong>Question Type</strong></th>
<th><strong>Question Text</strong></th>
<th><strong>Choice Text</strong></th>
<th><strong>Next Question ID</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>8998</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>8999</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>2</td>
<td>8999</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y </td>
<td>9000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>3</td>
<td>9000</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">14 days</span> with at least <span class="underline">two preferred</span> drugs?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>9002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>9001</td>
</tr>
<tr class="odd">
<td>4</td>
<td>9001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y</td>
<td>9002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>5</td>
<td>9002</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following product(s):</p>
<p>Generic fluocinolone 0.01% oil</p></td>
<td>Y</td>
<td>9003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>9004</td>
</tr>
<tr class="odd">
<td>6</td>
<td>9003</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the brand medication been attempted and failed or is the brand medication contraindicated?  </p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>7</td>
<td>9004</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>9005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>9006</td>
</tr>
<tr class="odd">
<td>8</td>
<td>9005</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>9006</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>9</td>
<td>9006</td>
<td></td>
<td>Select</td>
<td>Is the request for a low/medium potency agent or a high/very high potency agent?</td>
<td>Low/medium potency</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>High/very high potency</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td>10</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</td>
<td> Y    </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>11</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>12</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 days for low and medium potency; 90 days
for high and very high potency

| **Last Approved ** | 8/18/2023 |
| ------------------ | --------- |
| **Other**          |           |
